COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS

The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some e...

Full description

Saved in:
Bibliographic Details
Main Authors JON LOREN, BAO NGUYEN, HANK MICHAEL JAMES PETRASSI, XIAOLIN LI, VALENTINA MOLTENI, JULIET NABAKKA, VINCE YEH, XIAODONG LIU
Format Patent
LanguageEnglish
Spanish
Published 25.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases. La invención proporciona compuestos y composiciones farmacéuticas de los mismos, los cuales son útiles como inhibidores de las proteinas quinasas, así como también métodos para utilizar tales compuestos y así tratar, alivar o prevenir una condición asociada con actividad anormal o desregulada de las quinasas. En algunas realizaciones, la invención proporciona métodos para utilizar tales compuestos para tratar, aliviar o prevenir enfermedades o trastornos que involucran activación anormal de la c- kit o quinasas c- kit y PDGFR (PDGFRa, PDGFRß).
Bibliography:Application Number: MX20140002482